Stockscreener 앱 받기
1.09
3.54%
-0.04
시간 외 거래:
1.12
0.03
+2.75%
전일 마감가:
$1.13
열려 있는:
$1.13
하루 거래량:
216.91K
Relative Volume:
0.76
시가총액:
$97.78M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-1.1978
EPS:
-0.91
순현금흐름:
$-31.63M
1주 성능:
-13.49%
1개월 성능:
+12.51%
6개월 성능:
+25.72%
1년 성능:
-50.00%
1일 변동 폭
$1.052
$1.15
1주일 범위
$1.052
$1.34
52주 변동 폭
$0.49
$2.3257
Context Therapeutics Inc Stock (CNTX) Company Profile
명칭
Context Therapeutics Inc
전화
267-225-7416
주소
2001 MARKET STREET, PHILADELPHIA
CNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.09 | 101.37M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Guggenheim | Buy |
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2025-01-08 | 개시 | JMP Securities | Mkt Outperform |
| 2024-11-25 | 개시 | D. Boral Capital | Buy |
| 2024-05-16 | 개시 | Piper Sandler | Overweight |
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
Is Context Therapeutics Inc. a candidate for recovery play2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Is Context Therapeutics Inc. stock a defensive play in 2025Treasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Context Therapeutics Inc. stock trendline breakdownQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Is Context Therapeutics Inc. stock positioned well for digital economyJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Is Context Therapeutics Inc. trending in predictive chart modelsPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Real time scanner hits for Context Therapeutics Inc. explained2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What’s the recovery path for long term holders of Context Therapeutics Inc.Trade Performance Summary & Precise Swing Trade Alerts - newser.com
Is Context Therapeutics Inc. stock a top pick in earnings seasonNew Guidance & Breakout Confirmation Trade Signals - newser.com
What recovery options are there for Context Therapeutics Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Context Therapeutics Inc. stock resilient to inflationWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Context Therapeutics Grants Stock Options to New Hire - MSN
How to interpret RSI for Context Therapeutics Inc. stockM&A Rumor & Weekly High Conviction Ideas - newser.com
Does Context Therapeutics Inc. stock trade at a discount to peersPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Applying chart zones and confluence areas to Context Therapeutics Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Why hedge funds are buying Context Therapeutics Inc. stockEarnings Recap Summary & Precise Trade Entry Recommendations - newser.com
Exit strategy if you’re trapped in Context Therapeutics Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
What drives Context Therapeutics Inc stock priceEnergy Sector Updates & Small Budget Trading Ideas - earlytimes.in
Context Therapeutics (CNTX) Projected to Post Earnings on Wednesday - MarketBeat
Statistical indicators supporting Context Therapeutics Inc.’s strengthTake Profit & Weekly High Potential Alerts - newser.com
Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer - GlobeNewswire Inc.
Context Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Context Therapeutics (NASDAQ: CNTX) to join Guggenheim and Stifel investor conferences - Stock Titan
Context Therapeutics Inc (CNTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):